Guangdong Provincial People's Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1946-01-01

Employees: -

Market Cap: -

Website: http://www.gdghospital.org.cn

Clinical Trials

Dietary Protein Sources and Glycemic Variability

Not Applicable

Not yet recruiting

Conditions: Obesity
Diabetes
Metabolic Disease
Overweight
Dietary Protein

First Posted Date: 2024-07-29

Last Posted Date: 2024-07-31

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 96

Registration Number: NCT06525441

Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma

Phase 4

Recruiting

Conditions: Soft Tissue Sarcoma
Doxorubicin
Radiotherapy

Interventions: Drug: Anlotinib

First Posted Date: 2024-07-18

Last Posted Date: 2024-08-12

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 39

Registration Number: NCT06506838

Locations: 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
🇨🇳
Guangdong provincial people's hospital, Guangzhou, Guangdong, China

Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema

Phase 4

Recruiting

Conditions: Diabetic Macular Edema

Interventions: Drug: intravitreal injection of Brolucizumab 6 mg in study eye

First Posted Date: 2024-07-12

Last Posted Date: 2024-08-27

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 52

Registration Number: NCT06498050

Locations: 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China

A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules

Not yet recruiting

Conditions: Solitary Lung Nodule
Multiple Pulmonary Nodules

First Posted Date: 2024-06-13

Last Posted Date: 2024-12-02

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 1184

Registration Number: NCT06458673

Locations: 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China

The Effect of Preserving Inferior Pulmonary Ligamen on Symptom Burden in Thoracoscopic Pneumonectomy

Not Applicable

Not yet recruiting

Conditions: Pulmonary Surgical Procedures
Patient Reported Outcome Measures

Interventions: Procedure: Preserving IPL during surgery

First Posted Date: 2024-06-11

Last Posted Date: 2024-06-11

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 200

Registration Number: NCT06452680

Locations: 🇨🇳
The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
🇨🇳
Shantou University Medical College, Shantou, Guangdong, China
🇨🇳
The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, China

and more 2 locations

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Phase 2

Not yet recruiting

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Anthracyclines or anthraquinones
Drug: Chidamide
Drug: Venetoclax
Drug: cytarabine
Drug: azacitidine

First Posted Date: 2024-06-11

Last Posted Date: 2024-06-11

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 240

Registration Number: NCT06451861

Locations: 🇨🇳
Foshan First People's Hospital, Foshan, Guangdong, China
🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
🇨🇳
The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

and more 10 locations

Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection

Not Applicable

Recruiting

Conditions: Pulmonary Function Assessment
Disease Free Survival
NSCLC, Stage I

Interventions: Procedure: Wedge resection under watershed analysis method

First Posted Date: 2024-05-08

Last Posted Date: 2024-05-08

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 3000

Registration Number: NCT06404164

Locations: 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China

PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS

Phase 2

Not yet recruiting

Conditions: Colorectal Cancer

Interventions: Drug: standard advanced first-line regimen group
Drug: PCSK9 inhibitor in combination with standard advanced first-line regimen group

First Posted Date: 2024-04-30

Last Posted Date: 2024-04-30

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 60

Registration Number: NCT06391905

Transfusion in Cardiac Valve Surgery

Not Applicable

Not yet recruiting

Conditions: Cardiac Surgery With Cardiopulmonary Bypass
Valve Heart Disease

Interventions: Other: Liberal Transfusion Strategy
Other: Restrictive Transfusion Strategy

First Posted Date: 2024-03-27

Last Posted Date: 2024-03-27

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 1600

Registration Number: NCT06332547

Locations: 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China

Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC

Phase 2

Recruiting

Conditions: Non Small Cell Lung Cancer
EGFR Gene Mutation

Interventions: Drug: almonertinib
Drug: Carboplatin
Drug: Nab paclitaxel

First Posted Date: 2024-03-08

Last Posted Date: 2024-04-17

Lead Sponsor: Guangdong Provincial People's Hospital

Target Recruit Count: 32

Registration Number: NCT06300424

Locations: 🇨🇳
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy